MedPath

Senju Pharmaceutical Science&Technology(Beijing)Co.,Ltd

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:1
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease

Phase 3
Active, not recruiting
Conditions
Dry Eye
Interventions
Drug: Placebo
First Posted Date
2024-12-04
Last Posted Date
2025-07-17
Lead Sponsor
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd.
Target Recruit Count
427
Registration Number
NCT06717152
Locations
🇨🇳

Beijing Hospital, Beijing, Beijing, China

🇨🇳

Beijing Tongren Hospital, Beijing, Beijing, China

🇨🇳

Peking Union Medical College Hospital, Beijing, Beijing, China

and more 32 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.